| Authors: |
Farberov S; Department of Immunology and Regenerative Biology and Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel., Ziv O; Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK. omer.ziv@gmail.com.; Eleven Therapeutics, Cambridge, UK. omer.ziv@gmail.com., Lau JY; MRC Human Genetics Unit, University of Edinburgh, Edinburgh, UK., Ben-Tov Perry R; Department of Immunology and Regenerative Biology and Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel., Lubelsky Y; Department of Immunology and Regenerative Biology and Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel., Miska E; Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK. eam29@cam.ac.uk., Kudla G; MRC Human Genetics Unit, University of Edinburgh, Edinburgh, UK. gkudla@gmail.com., Ulitsky I; Department of Immunology and Regenerative Biology and Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel. igor.ulitsky@weizmann.ac.il. |
